Hírek

Pályázati hírek - 2005. szeptember 13, kedd

Pályazati lehetőségek az élettudományok területén- FP6

Néhány téma az infonap kínálatából.

· A systems approach to understanding the regulation of gene transcription · Structural genomics interdisciplinary initiative · Functional genomics in /Arabidopsis thaliana/ · High throughput phenotyping tools and approaches for large scale functional genomics studies · Population cohorts for molecular epidemiological studies in European and other populations · Functional genomics of autosomal aneuploid syndromes · The biological role of small regulatory RNAs – · Rational and accelerated development of new, safer, more effective drugs including · pharmacogenomics approaches · Marker profiling as a new tool for predictive toxicology · New tools to investigate ADME properties of drugs involving a carrier system · Rational and accelerated development of new, safer, more effective drugs including pharmacogenomics approaches · High throughput molecular diagnostics for hereditary diseases · Development of innovative methods for diagnosis of nervous system disorders · Nanoparticles-based diagnostics · Predictive /in vitro /testing strategies for human exposure to chemicals - · Workshop on business opportunities for /in vitro /pharmaceutical toxicology · Forum for researchers and regulators to meet manufacturers of toxicology test methods · Development of new in vitro tests to replace animal experimentation · Development and testing of new preventive and therapeutic tools, such as somatic gene and cell therapies (in particular stem cell therapies, for example those on neurological and neuromuscular disorders) and immunotherapies/./ · Tissue engineering approaches to treating children with birth defects · Stem cell therapy for stroke patients · Methodological research to underpin stem cell banking · Understanding monogenic rare diseases using insight from stem cell lines · Use of baculovirus as a vector in gene therapy (especially orientated towards small and medium sized companies) · Application of post-genomics to xenotransplantation research · Post-genomic approaches exploiting aquatic molecular biodiversity for biomedical applications · Use of cell lines to define new bioassays for the identification of therapeutic bio-molecules (especially orientated towards small and medium sized companies · Genetic control of the pathogenesis of diseases based on iron metabolism · Genome-wide mapping and functional genomics of susceptibility to coronary artery disease · Hypertension and cardiovascular disease · Molecular, genomic and applied genomic studies for the prevention of accelerated cardiovascular death in uraemia and end-stage renal disease · Functional genomics and regulatory networks in lipid · metabolism and their effects on the development of atherogenic vascular disease - · Gene-environment interaction on the incidence of type 2 · diabetes · Molecular pathways underlying decreased beta cell mass in · diabetes mellitus · Rare inherited neuromuscular disorders: from molecular basis to cutting edge · Rare disorders of protein folding. · Rare diseases of connective tissues affecting bone and/or cartilage/:/ · Research on cardiovascular disease with strong SME involvement · Development of preventive and therapeutic strategies for Type 1 diabetes with strong SME involvement · Development of /in vitro /and/or animal models for rare diseases · Combating resistance to antibiotics and other drugs · Control of antimicrobial resistance in hospital acquired and other health care associated infections · Molecular ecology of antibiotic drug resistance · Workshop exploring novel opportunities towards the development of vaccines that will have a significant impact on the control of antibacterial resistance // · Development of new diagnostic tests for the management and control of antimicrobial resistance · Development of novel principles for anti-microbial treatment /–/ · Studying the brain and combating diseases of the nervous system · Neuroimaging: “Bridging genetics and neural function” /–/ · Functional genomics and neurobiology of epilepsy – · Cortical information processing · Schizophrenia: from genotype to phenotype · Initiative in neuroinformatics · Neuroscience-oriented new technologies · Characterisation and use of animal models for neurological and psychiatric diseases · Early markers and new targets for neurodegenerative diseases · Perinatal brain damage: early markers and neuroprotection /–/ · Integration of research in development and ageing - · Attracting researchers to ageing research/:/ · Understanding the responsiveness of elderly people towards vaccination and infectious diseases Helyszín: Kis Tanács

Hírarchívum